Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,778.00
Bid: 1,774.00
Ask: 1,774.50
Change: -10.50 (-0.59%)
Spread: 0.50 (0.028%)
Open: 1,796.00
High: 1,808.50
Low: 1,772.50
Prev. Close: 1,788.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS: Bernstein Raises Tesco And Cuts Morrisons

Mon, 08th Sep 2014 08:35

LONDON (Alliance News) - The following UK shares received analyst recommendations Monday morning:
----------
FTSE 100
----------
BERNSTEIN RAISES TESCO TO 'MARKET-PERFORM' ('UNDERPERFORM') - PRICE TARGET 235 PENCE
----------
BERNSTEIN CUTS MORRISON TO 'UNDERPERFORM' ('MARKET-PERFORM') - PRICE TARGET 140 (180) PENCE
----------
CS CUTS GLAXOSMITHKLINE PRICE TARGET TO 1400 (1475) PENCE - 'UNDERPERFORM'
----------
DEUTSCHE BANK RAISES BARCLAYS PRICE TARGET TO 300 (285) PENCE - 'BUY'
----------
JPMORGAN RAISES BARRATT DEVELOPMENTS TO 'OVERWEIGHT.' ('NEUTRAL') - PT 460 (440) PENCE
----------
JPMORGAN RAISES INTU PROPERTIES PRICE TARGET TO 340 (305) PENCE - 'UNDERWEIGHT'
----------
JPMORGAN RAISES PERSIMMON PRICE TARGET TO 1650 (1570) PENCE - 'OVERWEIGHT'
----------
JPMORGAN CUTS DIAGEO PRICE TARGET TO 1730 (1760) PENCE - 'UNDERWEIGHT'
----------
HSBC CUTS HARGREAVES LANSDOWN PRICE TARGET TO 850 (950) PENCE - 'UNDERWEIGHT'
----------
CITIGROUP RAISES RECKITT BENCKISER PRICE TARGET TO 6000 (5700) PENCE - 'BUY'
----------
FTSE 250
----------
JEFFERIES RAISES BODYCOTE PRICE TARGET TO 835 (825) PENCE - 'BUY'
----------
LIBERUM RAISES CARILLION PRICE TARGET TO 440 (420) PENCE - 'BUY'
----------
DEUTSCHE BANK CUTS PREMIER OIL PRICE TARGET TO 420 (495) PENCE - 'BUY'
----------
DEUTSCHE BANK CUTS AFREN PRICE TARGET TO 130 (175) PENCE - 'HOLD'
----------
JPMORGAN RAISES BELLWAY PRICE TARGET TO 2100 (2000) PENCE - 'OVERWEIGHT'
----------
JPMORGAN RAISES BERKELEY GROUP PRICE TARGET TO 2900 (2800) PENCE - 'OVERWEIGHT'
----------
JPMORGAN RAISES BOVIS HOMES PRICE TARGET TO 1000 (950) PENCE - 'NEUTRAL'
----------
JPMORGAN CUTS REDROW PRICE TARGET TO 330 (365) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES JLT GROUP PRICE TARGET TO 1260 (1180) PENCE - 'OVERWEIGHT'
----------
CITIGROUP CUTS SYNERGY HEALTH TO 'NEUTRAL' ('BUY') - TARGET 1600 (1145) PENCE
----------
NUMIS RAISES JUPITER FUND TO 'BUY' ('ADD') - TARGET 480 (475) PENCE
----------
NUMIS CUTS KAZAKHMYS PRICE TARGET TO 280 (290) PENCE - 'HOLD'
----------
MAIN MARKET AND AIM
----------
DEUTSCHE BANK CUTS SALAMANDER ENERGY TO 'HOLD' ('BUY') - TARGET 125 (185) PENCE
----------
JPMORGAN CUTS LONDON MINING TO 'NEUTRAL' ('OVERWEIGHT') - TARGET 27 (100) PENCE
----------
CANACCORD CUTS CHARLES STANLEY GROUP PRICE TARGET TO 385 (480) PENCE - 'BUY'
----------
CITIGROUP CUTS LAMPRELL TO 'NEUTRAL' ('BUY') - TARGET 177 PENCE
----------
NUMIS CUTS PETROPAVLOVSK PRICE TARGET TO 30 (60) PENCE - 'SELL'
----------
NUMIS RAISES RIVER & MERCANTILE PRICE TARGET TO 238 (235) PENCE - 'ADD'
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
23 May 2024 19:21

Zantac not a cause of woman’s cancer, jury says in first trial over drug

CHICAGO, May 23 (Reuters) - A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of lawsuits making similar allegations.

Read more
22 May 2024 22:59

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, May 22 (Reuters) -

Read more
21 May 2024 11:23

AstraZeneca aims for $80 bln in total revenue by 2030

Sees $80 bln in 2030 revenue by 2030

*

Read more
21 May 2024 08:49

GSK's depemokimab asthma treatment meets endpoints in latest trials

(Alliance News) - GSK PLC on Tuesday announced positive results from trials of depemokimab, an "ultra-long-acting biologic" that could simplify treatment options for patients with severe asthma.

Read more
21 May 2024 07:21

GSK reports promising results from asthma treatment trials

(Sharecast News) - GSK announced promising results from phase three clinical trials evaluating the efficacy and safety of depemokimab in treating severe asthma with type 2 inflammation on Tuesday.

Read more
20 May 2024 16:11

IN BRIEF: GSK executive buys GBP20,026 worth shares

GSK PLC - London-based pharmaceuticals firm - Senior Vice President, Global Communications & Chief Executive Office, Sally Jackson, buys 1,120 shares at 1,788 pence each. Worth total GBP20,026.

Read more
17 May 2024 17:38

London's FTSE nudges lower for week after record run

Haleon falls after GSK offloads remaining stake

*

Read more
17 May 2024 15:52

London close: Stocks recoup some earlier losses

(Sharecast News) - London stocks remained in negative territory by Friday's close, although they managed to recoup some of the losses seen earlier in the session as Wall Street opened with positive momentum.

Read more
17 May 2024 11:52

LONDON MARKET MIDDAY: FTSE 100 slides; Eurozone inflation steady

(Alliance News) - Stock prices in London were lacklustre at midday on Friday, as investors eye the trajectory of interest rates across the globe.

Read more
17 May 2024 09:03

TOP NEWS: GSK sells remaining Haleon stake for GBP1.25 billion

(Alliance News) - GSK PLC on Friday said it has sold its remaining shares in Haleon PLC, marking a total exit from its consumer healthcare spin-off.

Read more
17 May 2024 08:56

LONDON MARKET OPEN: FTSE 100 lacklustre as Wall Street rally ends

(Alliance News) - Stock prices in London opened lower on Friday, after Thursday saw Wall Street's rally end in a record breaking session.

Read more
17 May 2024 08:39

GSK raises $1.5 bln from sale of remaining Haleon stake

May 17 (Reuters) - British drugmaker GSK has raised 1.25 billion pounds ($1.52 billion) from a sale of its remaining stake in consumer healthcare company Haleon to institutional investors.

Read more
17 May 2024 07:42

LONDON BRIEFING: Land Securities ups dividend; GSK sells Haleon stake

(Alliance News) - Stocks in London are called to open lower, as investors wait for an inflation reading from the eurozone later this morning.

Read more
17 May 2024 07:29

GSK raises £1.25bn from sale of remaining Haleon stake

(Sharecast News) - GSK said on Friday that it has sold its remaining 4.2% stake in consumer health business Haleon, which it spun off in July 2022.

Read more
16 May 2024 17:33

FTSE 100 ends lower on disappointing corporate updates, BT Group soars

BT Group up after CEO aims for more than double free cash flow

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.